International Clinical Psychopharmacology

Papers
(The H4-Index of International Clinical Psychopharmacology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?37
The role of personality traits in following quarantine orders during the COVID-19 pandemic29
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia18
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?17
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial17
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder16
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge14
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?13
Antidepressant psychopharmacology: is inflammation a future target?13
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure13
Managing depression in the elderly: real-world clinical considerations and perspectives11
Open issues in bipolar and antipsychotic treatments11
Clinical specificity profile for novel rapid acting antidepressant drugs11
0.042089939117432